stooocks.com

Understand any stock in simple English

Revolution Medicines, Inc.

United States · NASDAQ: RVMD · Market cap: · P/E: · P/S:

Revolution Medicines develops targeted cancer drugs that go after cancers driven by RAS mutations.

Revolution Medicines is a cancer drug company with a very specific obsession: cancers caused by broken RAS genes. RAS is one of the most famous trouble-makers in cancer biology — mutations in these genes act like a gas pedal stuck to the floor, telling cells to grow and divide without stopping. These mutations show up in some of the deadliest cancers, including pancreatic, lung, and colorectal tumors, and for roughly forty years they were considered basically undruggable. Revolution Medicines is trying to change that.

Revolution Medicines, Inc. (RVMD) RASONQUE (daraxonrasib) cancer medicine: line art illustration of A medicine tablet bottle labeled RASONQUE with a single pill beside it
RASONQUE
RASONQUE is a targeted medicine for cancers driven by RAS mutations, including pancreatic cancer.

Its lead drug, daraxonrasib, is an oral pill designed to block multiple flavors of mutated RAS at once, rather than picking off one variant at a time. The company is also developing a family of related drugs and combinations aimed at the same target. Patients don't pay for this today — the company earns essentially no product revenue because the drugs are still in clinical trials. Instead, the business runs on investor capital: it raises money by selling shares, spends that money on years of expensive trials, and hopes to eventually win FDA approval and then get paid by insurers and patients when doctors prescribe its medicines.


That makes this a high-risk, high-reward bet rather than a steady business. The upside is enormous if the drugs work, because RAS-mutated cancers are common and current treatments are weak. The danger is equally real: clinical trials fail often, larger competitors like Amgen and Mirati-style rivals are chasing similar targets, and the company must keep raising cash until a drug reaches the market. Revolution Medicines is headquartered in Redwood City, California, and its science has attracted serious attention and money from investors who believe RAS is finally cracked.

Saved answer · last researched 17 Nov 2026